A potent /-peptide analogue of GLP-1 with prolonged action in vivo
The questions worth specifically confirming: whether your health data is used for any secondary purpose beyond your direct care management (marketing, analytics, research)
References consulted in writing this blog post: Jaime P Almandoz 1 , Thomas A Wadden 2 , Colleen Tewksbury 3 , Caroline M Apovian 4 , Angela Fitch 5 , Jamy D Ard 6 , Zhaoping Li 7 , Jesse Richards 8 , W Scott Butsch 9 , Irina Jouravskaya 10 , Kadie S Vanderman 11 , Lisa M Neff 10
About 5,200 people participated in the initial clinical trials for Januvia
Back Unger, RH, Ketterer, H Dupr, J, Eisentraut, I (1967) 'The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs', Journal Clinical Investigation , 46/4, 63045